文献速递骨肿瘤关节外科

癌症患者大段假体保肢术后金属离子释放

Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery.
PubMed 文献 · J Arthroplasty · 2024-04-18

该回顾性描述性队列分析纳入2010至2020年在本院接受癌症相关保肢手术并置入大段假体的22例患者,前瞻性采集血样测定钛、铬、钴离子浓度。结果显示铬升高占22.7%、钴升高占68.2%(其中毒性水平9.1%)、钛升高占77.3%(其中毒性水平22.7%),术后化疗与钛离子水平显著相关(P=0.017)。

要点

  • 大段假体保肢术后钛升高者占77.3%,其中毒性水平占22.7%。
  • 钴升高者占68.2%,其中毒性水平占9.1%;铬升高者占22.7%。
  • 术后化疗与钛离子水平显著相关(P=0.017)。

核心结论

  • 癌症相关大段假体保肢手术与超过既定安全阈值的金属离子水平相关。
  • 与传统髋关节置换术相比,本队列中更高比例的患者出现金属离子水平升高。

研究设计与样本

  • 回顾性描述性队列分析,纳入2010至2020年在本院接受癌症相关保肢手术并置入大段假体的患者,基线及随访数据取自临床和手术记录,血样为前瞻性获取。

主要发现

  • 研究期间共71例患者接受保肢手术,其中22例(女10例、男12例)纳入研究,平均年龄52岁(范围21至80岁)。
  • 多数病例累及股骨(16例,72.7%),多数患者接受全膝大段假体手术(14例,63.6%)。
  • 45%(10例)需行假体翻修手术,初次与翻修手术平均间隔4.32年,翻修术后平均随访4.05年。
  • 铬升高者占22.7%(5例);钴升高者占68.2%(15例),其中毒性水平占9.1%(2例);钛升高者占77.3%(17例),其中毒性水平占22.7%(5例)。
  • 术后化疗与钛离子水平显著相关(P=0.017);金属离子水平与初次或翻修手术后时间、以及初次至翻修手术时间均无相关性。

局限性

  • 证据等级为III级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Megaprostheses contain many more modular components than conventional total hip and knee arthroplasty, which may lead to higher serum levels of metal ions. The aim of this study was to determine serum concentrations of titanium, chromium, and cobalt ions in cancer patients after limb salvage surgery with a megaprosthesis. METHODS: A retrospective, descriptive cohort analysis consisting of patients who underwent cancer-related limb salvage surgery with a megaprosthesis at our hospital between 2010 and 2020 was conducted. Baseline and follow-up data were extracted from clinical and surgical records. Blood samples were prospectively obtained. Descriptive statistics were used for the analysis. RESULTS: A total of 71 patients underwent limb salvage surgery during the study period. Of these, 22 (10 women, 12 men) were included in the study. The mean age was 52 years (range, 21 to 80). Most cases (n = 16; 72.7%) involved the femur. Most patients (n = 14, 63.6%) underwent total knee megaprosthesis surgery. Implant revision surgery was required in 45% of cases (n = 10), with a mean interval of 4.32 years between the initial and revision surgeries. The mean follow-up time after revision surgery was 4.05 years. High levels of chromium were observed in 22.7% of patients (n = 5). High cobalt levels were found in 68.2% (n = 15) of patients, with toxic levels in 9.1% (n = 2). Titanium levels were high in 77.3% (n = 17) of cases and toxic in 22.7% (n = 5). Postoperative chemotherapy was significantly associated with titanium levels (P = .017). No correlation was observed between metal ion levels and time from primary or revision surgery or time from the first to revision surgery. CONCLUSIONS: This study shows that cancer-related limb salvage surgery with megaprosthesis is associated with metal ion levels that exceed established safe thresholds. Compared to conventional hip arthroplasty, a higher proportion of the patients in this cohort presented elevated levels of metal ions. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Fa-Binefa M, Rojas-Sayol R, Peiró A, et al. Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery. J Arthroplasty. 2024. PMID: 38640965. doi:10.1016/j.arth.2024.04.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。